eF-site ID 2oje-ABCDEFGH
PDB Code 2oje
Chain A, B, C, D, E, F, G, H

click to enlarge
Title Mycoplasma arthritidis-derived mitogen complexed with class II MHC molecule HLA-DR1/HA complex in the presence of EDTA
Classification IMMUNE SYSTEM
Compound HLA class II histocompatibility antigen, DR alpha chain precursor
Source Homo sapiens (Human) (2OJE)
Sequence A:  KEEHVIIQAEFYLNPDQSGEFXFDFDGDEIFHVDXAKKET
VWRLEEFGRFASFEAQGALANIAVDKANLEIXTKRSNYTP
ITNVPPEVTVLTNSPVELREPNVLICFIDKFTPPVVNVTW
LRNGKPVTTGVSETVFLPREDHLFRKFHYLPFLPSTEDVY
DCRVEHWGLDEPLLKHWEFD
B:  GDTRPRFLWQLKFECHFFNGTERVRLLERCIYNQEESVRF
DSDVGEYRAVTELGRPDAEYWNSQKDLLEQRRAAVDTYCR
HNYGVGESFTVQRRVEPKVTVYPSKTQPLQHHNLLVCSVS
GFYPGSIEVRWFRNGQEEKAGVVSTGLIQNGDWTFQTLVM
LETVPRSGEVYTCQVEHPSVTSPLTVEWRA
C:  PKYVKQNTLKLAT
D:  SMKLRVENPKKAQKHFVQNLNNVVFTNKELEDIYNLSNKE
ETKEVLKLFKLKVNQFYRHAFGIVNDYNGLLEYKEIFNMM
FLKLSVVFDTQRKEANNVEQIKRNIAILDEIMAKADNDLS
YFISQNKNFQELWDKAVKLTKEMKIKLKGQKLDLRDGEVA
INKVRELFGSDKNVKELWWFRSLLVKGVYLIKRYYEGDIE
LKTTSDFAKAVFED
E:  KEEHVIIQAEFYLNPDQSGEFXFDFDGDEIFHVDXAKKET
VWRLEEFGRFASFEAQGALANIAVDKANLEIXTKRSNYTP
ITNVPPEVTVLTNSPVELREPNVLICFIDKFTPPVVNVTW
LRNGKPVTTGVSETVFLPREDHLFRKFHYLPFLPSTEDVY
DCRVEHWGLDEPLLKHWEFD
F:  GDTRPRFLWQLKFECHFFNGTERVRLLERCIYNQEESVRF
DSDVGEYRAVTELGRPDAEYWNSQKDLLEQRRAAVDTYCR
HNYGVGESFTVQRRVEPKVTVYPSKTQPLQHHNLLVCSVS
GFYPGSIEVRWFRNGQEEKAGVVSTGLIQNGDWTFQTLVM
LETVPRSGEVYTCQVEHPSVTSPLTVEWRA
G:  PKYVKQNTLKLAT
H:  SMKLRVENPKKAQKHFVQNLNNVVFTNKELEDIYNLSNKE
ETKEVLKLFKLKVNQFYRHAFGIVNDYNGLLEYKEIFNMM
FLKLSVVFDTQRKEANNVEQIKRNIAILDEIMAKADNDLS
YFISQNKNFQELWDKAVKLTKEMKIKLKGQKLDLRDGEVA
INKVRELFGSDKNVKELWWFRSLLVKGVYLIKRYYEGDIE
LKTTSDFAKAVFED
Description


Functional site

1) chain A
residue 61
type
sequence A
description BINDING SITE FOR RESIDUE PO4 D 214
source : AC1

2) chain C
residue 310
type
sequence K
description BINDING SITE FOR RESIDUE PO4 D 214
source : AC1

3) chain D
residue 11
type
sequence A
description BINDING SITE FOR RESIDUE PO4 D 214
source : AC1

4) chain D
residue 12
type
sequence Q
description BINDING SITE FOR RESIDUE PO4 D 214
source : AC1

5) chain D
residue 14
type
sequence H
description BINDING SITE FOR RESIDUE PO4 D 214
source : AC1

6) chain D
residue 113
type
sequence K
description BINDING SITE FOR RESIDUE PO4 D 214
source : AC1

7) chain D
residue 117
type
sequence D
description BINDING SITE FOR RESIDUE PO4 D 214
source : AC1

8) chain A
residue 58
type
sequence G
description BINDING SITE FOR RESIDUE PO4 C 202
source : AC2

9) chain C
residue 307
type
sequence K
description BINDING SITE FOR RESIDUE PO4 C 202
source : AC2

10) chain C
residue 310
type
sequence K
description BINDING SITE FOR RESIDUE PO4 C 202
source : AC2

11) chain D
residue 10
type
sequence K
description BINDING SITE FOR RESIDUE PO4 C 202
source : AC2

12) chain D
residue 113
type
sequence K
description BINDING SITE FOR RESIDUE PO4 C 202
source : AC2

13) chain G
residue 310
type
sequence K
description BINDING SITE FOR RESIDUE PO4 H 214
source : AC3

14) chain H
residue 11
type
sequence A
description BINDING SITE FOR RESIDUE PO4 H 214
source : AC3

15) chain H
residue 12
type
sequence Q
description BINDING SITE FOR RESIDUE PO4 H 214
source : AC3

16) chain H
residue 14
type
sequence H
description BINDING SITE FOR RESIDUE PO4 H 214
source : AC3

17) chain H
residue 113
type
sequence K
description BINDING SITE FOR RESIDUE PO4 H 214
source : AC3

18) chain H
residue 117
type
sequence D
description BINDING SITE FOR RESIDUE PO4 H 214
source : AC3

19) chain E
residue 55
type
sequence E
description BINDING SITE FOR RESIDUE PO4 E 204
source : AC4

20) chain E
residue 58
type
sequence G
description BINDING SITE FOR RESIDUE PO4 E 204
source : AC4

21) chain G
residue 310
type
sequence K
description BINDING SITE FOR RESIDUE PO4 E 204
source : AC4

22) chain B
residue 19
type CARBOHYD
sequence N
description N-linked (GlcNAc...) asparagine => ECO:0000269|PubMed:19303388, ECO:0000269|PubMed:24190431
source Swiss-Prot : SWS_FT_FI3

23) chain F
residue 19
type CARBOHYD
sequence N
description N-linked (GlcNAc...) asparagine => ECO:0000269|PubMed:19303388, ECO:0000269|PubMed:24190431
source Swiss-Prot : SWS_FT_FI3

24) chain A
residue 53
type SITE
sequence S
description Self- and pathogen-derived peptide antigen => ECO:0000269|PubMed:17583734, ECO:0000269|PubMed:21115828, ECO:0000269|PubMed:31619516, ECO:0000269|PubMed:8145819
source Swiss-Prot : SWS_FT_FI4

25) chain E
residue 53
type SITE
sequence S
description Self- and pathogen-derived peptide antigen => ECO:0000269|PubMed:17583734, ECO:0000269|PubMed:21115828, ECO:0000269|PubMed:31619516, ECO:0000269|PubMed:8145819
source Swiss-Prot : SWS_FT_FI4

26) chain B
residue 57
type BINDING
sequence D
description BINDING => ECO:0000269|PubMed:31619516, ECO:0000269|PubMed:8145819
source Swiss-Prot : SWS_FT_FI1

27) chain B
residue 61
type BINDING
sequence W
description BINDING => ECO:0000269|PubMed:31619516, ECO:0000269|PubMed:8145819
source Swiss-Prot : SWS_FT_FI1

28) chain B
residue 81
type BINDING
sequence H
description BINDING => ECO:0000269|PubMed:31619516, ECO:0000269|PubMed:8145819
source Swiss-Prot : SWS_FT_FI1

29) chain B
residue 82
type BINDING
sequence N
description BINDING => ECO:0000269|PubMed:31619516, ECO:0000269|PubMed:8145819
source Swiss-Prot : SWS_FT_FI1

30) chain F
residue 57
type BINDING
sequence D
description BINDING => ECO:0000269|PubMed:31619516, ECO:0000269|PubMed:8145819
source Swiss-Prot : SWS_FT_FI1

31) chain F
residue 61
type BINDING
sequence W
description BINDING => ECO:0000269|PubMed:31619516, ECO:0000269|PubMed:8145819
source Swiss-Prot : SWS_FT_FI1

32) chain F
residue 81
type BINDING
sequence H
description BINDING => ECO:0000269|PubMed:31619516, ECO:0000269|PubMed:8145819
source Swiss-Prot : SWS_FT_FI1

33) chain F
residue 82
type BINDING
sequence N
description BINDING => ECO:0000269|PubMed:31619516, ECO:0000269|PubMed:8145819
source Swiss-Prot : SWS_FT_FI1

34) chain B
residue 93
type BINDING
sequence R
description BINDING => ECO:0000269|PubMed:8145819
source Swiss-Prot : SWS_FT_FI2

35) chain F
residue 93
type BINDING
sequence R
description BINDING => ECO:0000269|PubMed:8145819
source Swiss-Prot : SWS_FT_FI2

36) chain E
residue 49
type BINDING
sequence G
description BINDING => ECO:0000269|PubMed:8145819
source Swiss-Prot : SWS_FT_FI2

37) chain E
residue 52
type BINDING
sequence A
description BINDING => ECO:0000269|PubMed:8145819
source Swiss-Prot : SWS_FT_FI2

38) chain A
residue 55
type SITE
sequence E
description Pathogen-derived peptide antigen => ECO:0000269|PubMed:23260142, ECO:0007744|PDB:4GBX
source Swiss-Prot : SWS_FT_FI5

39) chain E
residue 55
type SITE
sequence E
description Pathogen-derived peptide antigen => ECO:0000269|PubMed:23260142, ECO:0007744|PDB:4GBX
source Swiss-Prot : SWS_FT_FI5

40) chain A
residue 62
type SITE
sequence N
description Self- and pathogen-derived peptide antigen => ECO:0000269|PubMed:17583734, ECO:0000269|PubMed:21115828, ECO:0000269|PubMed:23260142, ECO:0000269|PubMed:31619516, ECO:0000269|PubMed:8145819, ECO:0007744|PDB:4GBX
source Swiss-Prot : SWS_FT_FI6

41) chain E
residue 62
type SITE
sequence N
description Self- and pathogen-derived peptide antigen => ECO:0000269|PubMed:17583734, ECO:0000269|PubMed:21115828, ECO:0000269|PubMed:23260142, ECO:0000269|PubMed:31619516, ECO:0000269|PubMed:8145819, ECO:0007744|PDB:4GBX
source Swiss-Prot : SWS_FT_FI6

42) chain A
residue 69
type SITE
sequence N
description Pathogen-derived peptide antigen => ECO:0000269|PubMed:17583734, ECO:0000269|PubMed:21115828, ECO:0000269|PubMed:23260142, ECO:0000269|PubMed:8145819, ECO:0007744|PDB:4FQX, ECO:0007744|PDB:4GBX
source Swiss-Prot : SWS_FT_FI7

43) chain E
residue 69
type SITE
sequence N
description Pathogen-derived peptide antigen => ECO:0000269|PubMed:17583734, ECO:0000269|PubMed:21115828, ECO:0000269|PubMed:23260142, ECO:0000269|PubMed:8145819, ECO:0007744|PDB:4FQX, ECO:0007744|PDB:4GBX
source Swiss-Prot : SWS_FT_FI7

44) chain A
residue 76
type SITE
sequence R
description Self- and pathogen-derived peptide antigen => ECO:0000269|PubMed:17583734, ECO:0000269|PubMed:23260142, ECO:0000269|PubMed:31619516, ECO:0000269|PubMed:8145819, ECO:0007744|PDB:4FQX, ECO:0007744|PDB:4GBX
source Swiss-Prot : SWS_FT_FI8

45) chain E
residue 76
type SITE
sequence R
description Self- and pathogen-derived peptide antigen => ECO:0000269|PubMed:17583734, ECO:0000269|PubMed:23260142, ECO:0000269|PubMed:31619516, ECO:0000269|PubMed:8145819, ECO:0007744|PDB:4FQX, ECO:0007744|PDB:4GBX
source Swiss-Prot : SWS_FT_FI8

46) chain A
residue 78
type CARBOHYD
sequence N
description N-linked (GlcNAc...) asparagine => ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:7477400
source Swiss-Prot : SWS_FT_FI9

47) chain A
residue 118
type CARBOHYD
sequence N
description N-linked (GlcNAc...) asparagine => ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:7477400
source Swiss-Prot : SWS_FT_FI9

48) chain E
residue 78
type CARBOHYD
sequence N
description N-linked (GlcNAc...) asparagine => ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:7477400
source Swiss-Prot : SWS_FT_FI9

49) chain E
residue 118
type CARBOHYD
sequence N
description N-linked (GlcNAc...) asparagine => ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:7477400
source Swiss-Prot : SWS_FT_FI9

50) chain D
residue 83-89
type prosite
sequence LSVVFDT
description LECTIN_LEGUME_BETA Legume lectins beta-chain signature. LSVVFDT
source prosite : PS00307

51) chain A
residue 161-167
type prosite
sequence YDCRVEH
description IG_MHC Immunoglobulins and major histocompatibility complex proteins signature. YDCRVEH
source prosite : PS00290

52) chain B
residue 171-177
type prosite
sequence YTCQVEH
description IG_MHC Immunoglobulins and major histocompatibility complex proteins signature. YDCRVEH
source prosite : PS00290


Display surface

Download
Links